125 related articles for article (PubMed ID: 7195216)
21. Effects of AR-L 115 BS on hemodynamics and contractility of the heart in cardiac patients.
Stauch M; Nechwatal W
Arzneimittelforschung; 1981; 31(1a):267-71. PubMed ID: 7195239
[TBL] [Abstract][Full Text] [Related]
22. [Animal studies on the tolerability of AR-L 115 BS (author's transl)].
Schneider P; Bauer M; Eckenfels A; Lehmann H; Lützen L; Ueberberg H
Arzneimittelforschung; 1981; 31(1a):226-32. PubMed ID: 7195227
[TBL] [Abstract][Full Text] [Related]
23. A new non-glycoside, non-adrenergic cardiotonic agent AR-L 115 BS. Hemodynamic proof of its efficacy after both i.v. and oral administration.
Thormann J; Kramer W; Schlepper M
Arzneimittelforschung; 1981; 31(1a):273-8. PubMed ID: 7195241
[TBL] [Abstract][Full Text] [Related]
24. Effects of AR-L 115 BS on arterial and venous muscle tone in vitro.
Nguyen DH; Rüdel R; Voss U
Arzneimittelforschung; 1981; 31(1a):197-9. PubMed ID: 7195220
[TBL] [Abstract][Full Text] [Related]
25. Ergometric and hemodynamic studies on a new cardiotonic agent AR-L 115 BS.
Pozenel H
Arzneimittelforschung; 1981; 31(1a):263-6. PubMed ID: 7195238
[TBL] [Abstract][Full Text] [Related]
26. [The effect of AR-L 115 BS on the function and oxygen consumption of isolated guinea pig atria as compared to g-strophanthin and theophylline].
Siess M; Stieler K; Seifart HJ
Arzneimittelforschung; 1981; 31(1a):165-70. PubMed ID: 7195213
[TBL] [Abstract][Full Text] [Related]
27. A new orally active positive inotropic substance: AR-L 115 BS.
Ruffmann KD; Mehmel HC; Kübler W
Arzneimittelforschung; 1981; 31(1a):271-3. PubMed ID: 7195240
[TBL] [Abstract][Full Text] [Related]
28. [Hemodynamic effects of a new positive inotropic agent (AR-L 115 BS) in ischemic and nonischemic myocardiopathies].
Colle JP; Ohayon J; Ledain L; Besse P
Arch Mal Coeur Vaiss; 1984 Dec; 77(13):1532-9. PubMed ID: 6440503
[TBL] [Abstract][Full Text] [Related]
29. Study of the acute effect of AR-L 115 BS, a new positive-inotropic agent in patients with exercise-induced heart failure.
Drexler H; Wollschläger H; Löllgen H; Just H
Arzneimittelforschung; 1981; 31(1a):259-62. PubMed ID: 7195237
[TBL] [Abstract][Full Text] [Related]
30. In vivo interaction of AR-L 115BS (Vardax) with the adrenergic nervous system.
Petein M; Pierpont GL; Francis GS; Cohn JN; From AH
J Cardiovasc Pharmacol; 1984; 6(6):1020-6. PubMed ID: 6084757
[TBL] [Abstract][Full Text] [Related]
31. Hemodynamic activity of different doses of sulmazole by infusion.
Mendiola-García A; Fernández-Fernández JL; Tello-Arias A; Camacho-Rivera B
Arzneimittelforschung; 1983; 33(11):1594-8. PubMed ID: 6686455
[TBL] [Abstract][Full Text] [Related]
32. Studies on the mechanism of the positive-inotropic action of AR-L 115 BS, a new cardiotonic drug.
Diederen W; Weisenberger H
Arzneimittelforschung; 1981; 31(1a):177-82. PubMed ID: 7195215
[No Abstract] [Full Text] [Related]
33. Sulmazole effects on mechanical performance of hypoxic and reoxygenated isolated mammalian myocardium.
Bonoron-Adèle S; Grellet J; Bricaud H; Tariosse L; Besse P
Arzneimittelforschung; 1986 Nov; 36(11):1572-7. PubMed ID: 3814219
[TBL] [Abstract][Full Text] [Related]
34. Effects of 3,4-dihydro-6-[4-(3,4-dimethoxybenzoyl)-1-piperazinyl] -2(1H)-quinolinone (OPC-8212), a new inotropic agent, on cardiotonic activity and coronary hemodynamics.
Inoue M; Hori M; Nakajima S; Kitakaze M; Fukunami M; Ishida Y; Abe H
Arzneimittelforschung; 1984; 34(3A):355-9. PubMed ID: 6540088
[TBL] [Abstract][Full Text] [Related]
35. Effect of sulmazole and pimobendan on contractility of skinned fibres from frog skeletal muscle.
Piazzesi G; Morano I; Rüegg JC
Arzneimittelforschung; 1987 Oct; 37(10):1141-3. PubMed ID: 3435586
[TBL] [Abstract][Full Text] [Related]
36. Effects of the new imidazopyridine CL 86-02-01 on isolated papillary muscle of guinea-pig hearts.
Studenik C; Lemmens-Gruber R; Heistracher P
Arzneimittelforschung; 1998 Jun; 48(6):637-40. PubMed ID: 9689419
[TBL] [Abstract][Full Text] [Related]
37. An analysis of the positive inotropic effect of AR-L 115 BS on isolated rat atria.
Diez J; Delgado C; Tamargo J
Arch Int Pharmacodyn Ther; 1984 May; 269(1):70-82. PubMed ID: 6466008
[TBL] [Abstract][Full Text] [Related]
38. Experimental effects of AR-L 115 BS on electrophysiology, contractility and relaxation parameters.
Gimeno JV; Cosín J; Martín G; Valls F; Mainar V; Guillén I
Arch Farmacol Toxicol; 1984 Dec; 10(3):143-50. PubMed ID: 6532322
[No Abstract] [Full Text] [Related]
39. A double blind crossover tolerance study of AR-L 115 BS in health volunteers.
Van Wayjen RG; vd Ende A; Schuijt C
Arzneimittelforschung; 1981; 31(1a):242-3. PubMed ID: 7195231
[TBL] [Abstract][Full Text] [Related]
40. [AR-L 115 BS, comparison of human metabolite pattern and biotransformation with other species].
Roth W; Prox A; Reuter A; Schmid J; Zimmer A; Zipp H
Arzneimittelforschung; 1981; 31(1a):232-5. PubMed ID: 7195228
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
